TAK
TAK
US8740602052
Takeda Pharmaceutical Company L
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 4.505.720.000.000 4.581.551.000.000
1.7%
Cost of Revenue 1.571.588.000.000 1.580.217.000.000
0.5%
Gross Profit 2.934.132.000.000 3.001.334.000.000
2.2%
2.469.681.000.000 2.534.964.000.000
2.6%
Operating Income 464.451.000.000 466.370.000.000
0.4%
Pretax Income -142.355.000.000 175.084.000.000
181.3%
Net Income Common Stockholders -152.390.000.000 107.928.000.000
241.2%
-- --
--
-- --
--
ende